KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBITDA (2016 - 2025)

Insulet (PODD) has disclosed EBITDA for 16 consecutive years, with $146.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 33.85% year-over-year to $146.3 million, compared with a TTM value of $473.8 million through Dec 2025, up 53.43%, and an annual FY2025 reading of $473.8 million, up 53.38% over the prior year.
  • EBITDA was $146.3 million for Q4 2025 at Insulet, up from $117.6 million in the prior quarter.
  • Across five years, EBITDA topped out at $146.3 million in Q4 2025 and bottomed at -$26.7 million in Q2 2022.
  • Average EBITDA over 5 years is $58.3 million, with a median of $52.1 million recorded in 2021.
  • The sharpest move saw EBITDA plummeted 201.52% in 2022, then surged 1789.66% in 2023.
  • Year by year, EBITDA stood at $49.7 million in 2021, then tumbled by 52.72% to $23.5 million in 2022, then surged by 353.19% to $106.5 million in 2023, then increased by 2.63% to $109.3 million in 2024, then skyrocketed by 33.85% to $146.3 million in 2025.
  • Business Quant data shows EBITDA for PODD at $146.3 million in Q4 2025, $117.6 million in Q3 2025, and $121.1 million in Q2 2025.